-
1
-
-
0344267641
-
Epidemiology of chronic daily headache in the general population
-
Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-196. (Pubitemid 29190083)
-
(1999)
Headache
, vol.39
, Issue.3
, pp. 190-196
-
-
Castillo, J.1
Munoz, P.2
Guitera, V.3
Pascual, J.4
-
2
-
-
58449103368
-
Management of medication overuse headache: 1-year randomized multicentre open-label trial
-
Hagen K, Albretsen C, Vilming ST, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 2009;29:221-232.
-
(2009)
Cephalalgia
, vol.29
, pp. 221-232
-
-
Hagen, K.1
Albretsen, C.2
Vilming, S.T.3
-
3
-
-
69949145993
-
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse
-
Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 2009;29:1021-1027.
-
(2009)
Cephalalgia
, vol.29
, pp. 1021-1027
-
-
Diener, H.C.1
Dodick, D.W.2
Goadsby, P.J.3
-
4
-
-
41849101483
-
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
-
DOI 10.1111/j.1468-2982.2008.01555.x
-
Silberstein S, Tfelt-Hansen P, Dodick D, et al, for the Task Force of the International Headache Society Clinical Trials. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008; 28:484-495. (Pubitemid 351502554)
-
(2008)
Cephalalgia
, vol.28
, Issue.5
, pp. 484-495
-
-
Silberstein, S.1
Tfelt-Hansen, P.2
Dodick, D.W.3
Limmroth, V.4
Lipton, R.B.5
Pascual, J.6
Wang, S.J.7
-
5
-
-
77953218035
-
OnabotulinumtoxinA for the treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of PREEMPT clinical program
-
PREEMPT Chronic Migraine Study Group
-
Dodick DW, Turkel CC, DeGryse RE, et al, PREEMPT Chronic Migraine Study Group. OnabotulinumtoxinA for the treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of PREEMPT clinical program. Headache 2010;50:921-936.
-
(2010)
Headache
, vol.50
, pp. 921-936
-
-
Dodick, D.W.1
Turkel, C.C.2
DeGryse, R.E.3
-
6
-
-
0346958580
-
Combined therapy for migraine prevention? Clinical experience with a β-blocker plus sodium valproate in 52 resistant migraine patients
-
DOI 10.1046/j.1468-2982.2003.00615.x
-
Pascual J, Leira R, Laínez JM. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 2003;23:961-962. (Pubitemid 37521948)
-
(2003)
Cephalalgia
, vol.23
, Issue.10
, pp. 961-962
-
-
Pascual, J.1
Leira, R.2
Lainez, J.M.3
-
7
-
-
33845871699
-
Testing the combination beta-blocker plus topiramate in refractory migraine
-
DOI 10.1111/j.1600-0404.2006.00772.x
-
Pascual J, Rivas MT, Leira R. Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand 2007;115:81-83. (Pubitemid 46018541)
-
(2007)
Acta Neurologica Scandinavica
, vol.115
, Issue.2
, pp. 81-83
-
-
Pascual, J.1
Rivas, M.T.2
Leira, R.3
-
8
-
-
84860787394
-
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine
-
Silberstein SD, Dodick DW, Lindblad AS, et al. Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine. Neurology 2012;78:976-984.
-
(2012)
Neurology
, vol.78
, pp. 976-984
-
-
Silberstein, S.D.1
Dodick, D.W.2
Lindblad, A.S.3
|